Search

everythinglearnresearchcommunity

for

Search:↓

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

An elderly Chinese man lost all his hair after taking a new heart medication.

Some blood pressure medications are linked to a higher risk of skin cancer.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Blood pressure medications may increase the risk of skin cancer.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Some common medications can lower PSA levels in 45-year-old German men.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

Vasodilators may worsen abdominal aortic aneurysm.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

The model and estimator can predict drug exposure in kidney transplant patients well.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.